XML 25 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Warrants
Other Comprehensive Gain (Loss)
Other Comprehensive Gain (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balance (in shares) at Dec. 31, 2017     166,989,790            
Balance at Dec. 31, 2017 $ 352,850 $ 0 $ 1,721 $ 1,400,758 $ 16,076 $ (2,095) $ (383) $ (1,063,610) $ 383
Increase (Decrease) in Stockholders' Equity                  
Stock issued from exercise of stock options, net (in shares)     1,397,908            
Stock issued from exercise of stock options, net 9,144   $ 14 9,130          
Stock issued from equity financing (in shares)     20,239,839            
Stock issued from equity financing 294,583   $ 202 294,381          
Restricted stock tax vesting (in shares)     303,173            
Restricted stock tax vesting (2,832)     (2,832)          
Stock-based compensation 29,260     29,260          
Warrants exercised (in shares)     453,214            
Warrants exercised 3,617   $ 5 6,625 (3,013)        
Change in fair value of derivatives 2,739     2,739          
Unrealized holding gain on available-for-sale securities 9         9      
Foreign currency translation adjustment 2,537         2,537      
Net loss (348,995)             (348,995)  
Balance (in shares) at Dec. 31, 2018     189,383,924            
Balance at Dec. 31, 2018 342,912   $ 1,942 1,740,061 13,063 68   (1,412,222)  
Increase (Decrease) in Stockholders' Equity                  
Stock issued from exercise of stock options, net (in shares)     1,967,087            
Stock issued from exercise of stock options, net 11,476   $ 20 11,456          
Stock issued from equity financing (in shares)     18,720,930            
Stock issued from equity financing 188,994   $ 187 188,807          
Restricted stock tax vesting (in shares)     477,198            
Restricted stock tax vesting (3,235)     (3,235)          
Stock issued for contingent consideration (in shares)     771,804            
Stock issued for contingent consideration 9,316   $ 8 9,308          
Stock-based compensation 44,430     44,430          
Warrants exercised (in shares)     101,787            
Warrants exercised 812   $ 1 1,487 (676)        
Equity component of the convertible notes (in shares)     43,995,139            
Equity component of the convertible notes 215,476   $ 440 215,036          
Termination of capped call confirmations 19,875     19,875          
Unrealized holding gain on available-for-sale securities 467         467      
Foreign currency translation adjustment 2,290         2,290      
Net loss $ (356,388)             (356,388)  
Balance (in shares) at Dec. 31, 2019 255,417,869   255,417,869            
Balance at Dec. 31, 2019 $ 476,425   $ 2,598 2,227,225 12,387 2,825   (1,768,610)  
Increase (Decrease) in Stockholders' Equity                  
Stock issued from exercise of stock options, net (in shares)     5,233,672            
Stock issued from exercise of stock options, net 42,282   $ 52 42,230          
Restricted stock tax vesting (in shares)     1,411,920            
Restricted stock tax vesting (10,028)     (10,028)          
Stock-based compensation 49,151     49,151          
Unrealized holding gain on available-for-sale securities (225)         (225)      
Foreign currency translation adjustment 5,627         5,627      
Net loss $ (276,852)             (276,852)  
Balance (in shares) at Dec. 31, 2020 262,063,461   262,063,461            
Balance at Dec. 31, 2020 $ 286,380   $ 2,650 $ 2,308,578 $ 12,387 $ 8,227   $ (2,045,462)